Geron (MIL:1GERN) Growth Rank: 0 (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1GERN Geron Corp MIL:1GERN
21 GF Score
Price €1.19
GF Value €6.11
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Geron Growth Rank?

Geron has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

MIL:1GERN
21GF Score
Geron Corp MIL:1GERN
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Geron (MIL:1GERN) Overvalued in 2026?

Based on GuruFocus' analysis, Geron stock appears to be undervalued. The current stock price of €1.19 is trading 80.5% below its estimated GF Value™ of €6.11. GuruFocus considers Geron to be Possible Value Trap.

Key valuation signals for MIL:1GERN:

  • Growth Rank: 0
  • GF Value™: €6.11 vs. price of €1.19 (80.5% below fair value)
  • GF Score™: 21/100 with 4 warning signs

No single metric tells the full story. See the MIL:1GERN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Geron Business Description

Other Exchanges GERN:USA0IV3:UKGON:Germany
Address 919 East Hillsdale Boulevard, Suite 250, Foster City, CA, USA, 94404
Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.
21GF Score

Get the complete analysis for MIL:1GERN

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.19
Price
€6.11
GF Value